Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotech VC Funds in Spain

Last updated: Apr 2024 A list of 50 VC funds that invest in Biotech startups based in Spain. We rank investors based on the number of investments they made in Biotech companies from Spain. We update this investor list every month.

Top 50 Biotech VC Funds in Spain

Investor	Biotech Spain investments
Centre for the Development of Industrial Technology (CDTI)	20
Caixa Capital Risc	18
SODENA	13
Inveready	12
ENISA	11
Invivo Capital Partners	10
Capital Cell	10
Asabys Partners	9
Ysios Capital	9
Alta Life Sciences	8
Clave	7
CRB Inverbío	7
BeAble Capital	7
Xesgalicia	6
CDTI	5
Seed Capital Bizkaia	4
Moira Capital Partners	4
BStartup	4
Bullnet Capital	4
Clave Mayor	4
Kurma Partners	3
Angels Capital	3
AdBio partners	3
Amadeus Capital Partners	3
Healthequity	2
Kinled Holding	2
Charme Capital Partners	2
Demium Capital	2
Blue Horizon Corporation	2
Eatable Adventures	2
Grow Venture Partners	2
Grupo Ferrer Internacional	2
Union Square Ventures	2
Pirate Impact	2
Josep Carreras Leukaemia Research Institute	2
Kereon Partners	2
Fitalent	2
Santander	2
Monte Carlo Capital	2
BAGi	2
Speedinvest	2
BoxOne Ventures	2
Amino Collective	2
AVANTECA Partners	2
EASO Ventures	2
Clave Capital	2
Nara Capital	2
Talis Capital	2
Green Generation Fund	1
CNTA	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Investment focus

Biotechnology, Health Care, Software
Funding Round, Seed, Grant
Spain, United States, France

Portfolio highlights

Ailin — Ailin offers digital health monitoring solutions with home self-sampling kits analyzed by Clínica Universidad de Navarra.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
KUMUX — Next generation smart-light devices

Caixa Capital Risc (CCR) is the VC arm of CriteriaCaixa which invests in innovative companies in their start-up and growth stages. The company has three specialised teams in the areas of Information Technology, Life Sciences, and Industrial technologies. Caixa Capital Risc currently manages more than €300m through 11 specialised vehicles.

Investment focus

Software, Biotechnology, E-Commerce
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

inari — INARI provides blockchain, machine learning and artificial intelligence technologies for the Insurance industry
AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
Mobile Media Content - TICKETING3D — Mobile Media Content, a Barcelona, Spain-based provider of virtual visualization technologies, raised €400k in seed funding.Founded in May 2012 by Michele Marino, CEO and Francis Casado, Head of Business Development, Mobile Media Content provides TICKETING3D, a SaaS 3D seating chart of a venue, which allows the final user to check the view fromhis seat before purchasing a ticket. It also Tranfer3D, which lets any club or sports organization to move supporters or fans from one location to another, and Match3D, a 2nd screening tool that allows following matches in real time.The company currently employs 20 people

SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.

Investment focus

Biotechnology, Health Care, Software
Debt Financing, Funding Round, Seed
Spain, United Kingdom

Portfolio highlights

MainRail — KEY BENEFITS Reduce maintenance costs by preventing unscheduled repairs and optimizing resource allocation. Increase the capacity of your network by minimizing the risk of service unavailability thanks to
Familiados — Familiados is a marketplace on line where families can find, select, and hire caregivers. Caregivers can create profiles, showing education, specialization, experience and availability; they also choose their hourly rate and the area where they want to work.Families, on their side, can search, find profiles with the specific skills for theirneed, request availability, close the deal directly with the caregiver and rate the service. All of it in an open platform, where familiados role is to facilitate the interaction, making sure that the profiles include true information, that families can evaluate their experience and that the transactions take place in a seamless and fluid way, from the beginning to the end, from selection to payment and evaluation.
Pyroistech — Pyroistech uses spectroscopy to create custom solutions for the industrial sector. With this method, a sample is illuminated, and the amount of light reflected or transmitted through it is measured. It is useful in a variety of fields: Agri-food industry, Construction, Medicine, and Other sectors.

We are a leading asset manager in Spain. We invest in early-stage VC, growth VC, venture debt, strategic public equity, private equity and infrastructure. Our different strategies allow us to provide financing solutions to companies throughout their life-cycle.

Investment focus

Software, Biotechnology, Information Technology
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

MedUX — MedUX is the leading Customer Experience and Network monitoring solution for telecommunication services, governments, and OTT providers by using AI Powered Real-Time Applied Analytics
Scaleup Finance — Improve your financial management
All Structured Notes — All Structured Notes is the fintech specialized in the democratization of structured notes.

ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.

Investment focus

Software, Health Care, E-Commerce
Seed, Debt Financing, Pre-Seed
Spain, United States, France

Portfolio highlights

Imageryst — Imageryst is a cutting-edge SaaS platform that uses artificial intelligence and remote sensing to automatically extract exact, worldwide geolocated data from satellite imagery.
Neuromindset — In an ever-evolving digital era, the mental abilities and emotional health of children often get overshadowed. Envision a world where the essence of education transcends mere knowledge, nurturing every child to unlock their cognitive and emotional prowess using evidence-based tools. At Neuromindset, a Spin-off of the University of Granada (Spain),this isn't just a dream—it's our mission. Our purpose? Seamlessly integrate cognitive and brain training into the very fabric of schooling and home environments. Our dual B2B and B2C models cater to educators and families alike, fortified by three pioneering instruments. Firstly, a classroom-integrated platform that provides educators with a training curriculum that includes mindfulness and game-based activities grounded in rigorous neuroscientific research, empowering students to enhance their attention, executive functions and self-regulation. Secondly, an interactive at-home gaming app, meticulously crafted to cultivate cognitive prowess, making the training both captivating and consequential. And lastly, our avant-garde AI assessment of attentional profiles, not just delineating a child's cognitive map but also tailoring their training, fortifying frailties, and magnifying mights. Neuromindset's hallmark is our dedication to fortify children's mental well-being, bolstering self-regulation, and providing AI-infused, personalized cognitive training. With Neuromindset, education it's not just about learning—it's about flourishing in every sense.
Muse Scene Lab — Perform with a virtual orchestra or band with Muse Scene Lab Suite and experiment: rehearsal enveloping, concert immersive experience, instrument selection, conductor & singer experience, all with classical, jazz, and popular repertoire.

Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.

Investment focus

Biotechnology, Health Care, Life Science
Seed, Funding Round, Series A
Spain, France, Belgium

Portfolio highlights

EsoBiotec — EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.EsoBiotec's objective is to enable the human body to fight cancer by delivering 'in vivo' cell engineering to patients.
Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.

Investment focus

Health Care, Biotechnology, Medical
Equity Crowdfunding, Funding Round, Seed
Spain, United States, United Kingdom

Portfolio highlights

Exheus — Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have.
MediQuo — MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction. Healthcare today has 75% of unnecessary medical visits that could be taken in the distance, and the vast majority of health professionals are using messaging platforms such as WhatsApp to communicate with patients or other health professionals.MediQuo is a chat-based app specialised in health, GDPR and health data compliant, giving professionals time control, incorporating patient medical history and phone privacy. Allowing also video and audio communication. It is a place for discussion, appointments or medical consultation with your doctor or any new health professional. Also includes immediate 24/7 medical response and a network, for health information and professional discovery. We have done already 1M consultations and got 600k app downloads. Our Google Play Ratings are 4,6 (with 6k reviews). We are amongst the top health apps in Spain and Latam.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Seed, Series B
Spain, Belgium, Germany

Portfolio highlights

Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
Gradient Denervation Technologies — Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
Spain, United States, Switzerland

Portfolio highlights

VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.

Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Funding Round, Seed
Spain, United States

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.

Clave is an investment management company.

Investment focus

Biotechnology, Health Care, Software
Seed, Series A, Funding Round
Spain, Chile, Switzerland

Portfolio highlights

Shakers — We are Shakers and we are redefining the future of work. We connect companies and talent with a perfect match between personal and professional life through technology and methodology. We want to achieve a lifestyle in which work is synonymous with happiness so that you can work where, how and when you want. And thus be more productive and havebetter results in the projects in which you collaborate. Sounds good to you? You already have DNA Shakers, follow us !!
MainRail — KEY BENEFITS Reduce maintenance costs by preventing unscheduled repairs and optimizing resource allocation. Increase the capacity of your network by minimizing the risk of service unavailability thanks to
D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.

CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies

Investment focus

Medical, Health Care, Biotechnology
Series A, Funding Round, Seed
Spain, Mexico

Portfolio highlights

Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
Biocross — Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.
Aglaris Ltd — Aglaris is developing an automated cell culture bioreactor for the mass production of human stem cells.Aglaris produces equipment to ensure cell and tissue culture is an easy, problem-free task. By automating and controlling the cell culture processes, we can obtain cells and tissues with sufficient quality to revitalize regenerative medicine andcell therapies. The technology used by our equipment is unique and is protected by international patents.

BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.

Investment focus

Biotechnology, Manufacturing, Medical Device
Pre-Seed, Seed, Funding Round
Spain, Italy

Portfolio highlights

KUMUX — Next generation smart-light devices
Materials Invisible to Oxygen — Materials Invisible to Oxygen (MITO) is a materials science company that develops corrosion control methods for metal surfaces. Their key products include technology that protects metal surfaces from harsh environmental conditions like humidity, high temperatures, and salinity.
A4CELL — A4CELL is a company that develops SPAchip (Suspended Planar-Array Chips) that helps to monitor living single cell.

XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.

Investment focus

Software, Biotechnology, Pharmaceutical
Seed, Funding Round, Pre-Seed
Spain, Portugal

Portfolio highlights

Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.

Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Debt Financing
Spain, United States, Mexico

Portfolio highlights

Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
Atlas Molecular Pharma — Latest News Your browser does not support the video tag.

Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de InnovaciÃ³n y PromociÃ³n EconÃ³mica de la DiputaciÃ³n Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called â€œSeed Capital Bizkaia, F.C.R.â€.

Investment focus

Software, Biotechnology, Health Care
Seed, Funding Round, Series A
Spain

Portfolio highlights

Fisify — Fisify is a physical treatment clinic, that creates technologies to make people's life easier and offers the requested services as well as commercial communications.
H2SITE — We provide fully integrated systems to produce on-site high quality hydrogen.
CLCircular — CLCircular is a digital company that provides real-time monitoring of logistics by implementing Big data, smart tags, and IoT devices.

Moira Capital Partners is private equity firm

Investment focus

Biotechnology, Information Technology, 3D Technology
Funding Round, Series A, Private Equity
Spain

Portfolio highlights

cimico — cimico is a biotechnological wastewater treatment solution for both urban and industrial contexts.
BioFlyTech — Bioflytech is an animal feed firm that specializes in the commercial manufacture of insect protein. Incorporating insect protein into current value chains, such as companion animal, aquaculture, or poultry, increases the circularity and sustainability of existing food chains. As a result, more proteins are produced while minimizing environmentaleffect and lowering water consumption and antibiotic use in the food production chain.
The Wise Seeker — The Wise Seeker specializes in recruiting, employment, digital assessment, consulting, digital evaluation, and human resource services.

A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Pre-Seed
Spain

Portfolio highlights

toddl.co — Book classes, camps and events for your kids in less than 3 clicks
Ocean Ecostructures — Ocean Ecostructures is the developer of a biodiversity regeneration program that will assist businesses and governments in transitioning to a blue economy.
Nanobots Therapeutics — Nanobots Therapeutics is a deeptech firm focused on the development and commercialization of the MotionTx platform. MotionTx technology enables the development of novel therapeutic entities with better efficacy in penetrating tissues and increasing drug accumulation in target cells.

Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses

Investment focus

Software, Information Technology, Enterprise Software
Funding Round, Series A, Seed
Spain, United States, Mexico

Portfolio highlights

Quside — Our QRNGs let innovators build advanced solutions for cybersecurity and computation.
wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using
Deep Detection — Multispectral x-ray camera for food & beverage inspection

Clave Mayor is a management company of closed investment entities based in Navarra.

Investment focus

Software, Biotechnology, Medical
Funding Round, Seed, Series A
Spain, Germany, United States

Portfolio highlights

Jeff — Jeff is a company created in 2015 by Eloi Gómez, Adrián Lorenzo and Rubén Muñoz, three Spanish entrepreneurs. It started as a home laundry and dry-cleaning app, but is currently in an expansion process in which, in addition to laundry service, different day-to-day services are added such as hairdressing and beauty, fitness and massages, becomingthe first international omnichannel ecosystem of day-to-day services. It is available to anyone who wants to invest or undertake the necessary solutions to launch their own business under the business lines of the Jeff brand.
Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
Predictheon — Predictive monitoring for clinicians. Real-time predictions about patient health status to personalize medical care, adjust and individualize therapy, and improve safety.

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Series B, Seed
France, Spain, Switzerland

Portfolio highlights

Poppins — Mila merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, weleverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
Shorla Pharma — Shorla Pharma is an Irish specialty pharmaceutical company. It is growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.

Angels Capital philosophy is to find and support at 1 able to lead a project. Their goal is to support the entrepreneurial, helping to create new businesses, help grow their business sector, generate employment and create wealth.

Investment focus

Software, Financial Services, Health Care
Seed, Angel, Funding Round
Spain, United States

Portfolio highlights

Uelz — Fixme provides an online platform that enables service based SMBs to create and manage online their businesses. From creating a full personalized website with service and product e-commerce to integrate with the industry best marketplaces and help them to grow on the internet from day one.
Flipflow — Flipflow is a SAAS company developing the most advanced price and ecommerce data monitoring BI software. We offer our customers accurate market data and a very powerfull and flexible BI platform and automation tools so they can maximize competitiveness, profitability and margins and take better business decisions.
Imperia — We provide to our clients tools for managing and optimizing their processes in the area of operations through an innovative, advanced and user-friendly software solution. Analytics Demand Planning (ADP) is a complete solution to support the demand forecasting process, based on two key pillars: 1. Easy-to-use: the solution is fully integrated inExcel, providing great ease of use and minimum implementation times. “If you know how to use Excel, you know how to use ADP”. 2. Collaborative planning: the tool is developed under a collaborative environment in which all members of the organization can be involved in the process, improving the decision-making process.Furthermore, it has great computing power based on statistical models and a wide range of advanced functionalities that add extra value to the product. Such as reference segmentation, intelligent cleaning of historical data series and integrated dashboards for sales and forecast analytics.

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Seed, Series A, Funding Round
France, Spain, Belgium

Portfolio highlights

Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
Anoat Therapeutics — Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Investment focus

Software, Artificial Intelligence, Machine Learning
Series B, Seed, Series A
United Kingdom, United States, Spain

Portfolio highlights

Sitehop — Sitehop is a technology company creating innovative solutions for cyber-security and networking. Sitehop utilizes its custom FPGA solutions to optimize and accelerate cloud/telco networks.
Secondmind — Helping automotive engineers design better cars, faster.
Photonic — We are building a new world through scalable, fault-tolerant quantum technologies.

Healthequity is a venture capital company specializing in early-stage projects in the health sector: medical devices, biotechnology and healthcare services. It is a fund promoted by the Official College of Physicians of Barcelona and the financial group Riva y Garcia that is looking for projects to make their first investments. Healthequity has ateam of professionals with complementary experience, with the scientific-technical and financial know-how necessary to analyze and make investments contributing value to the investee company. In addition, it has a network of contacts and key strategic relationships in the health ecosystem.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series D
Spain, Switzerland

Portfolio highlights

SANIFIT — A new approach to calcification disorders.
Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Versantis — Versantis is a Swiss pharmaceutical company, Spin-off of ETH Zurich, developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide. Its lead candidate, VS-01, iscurrently at preclinical stage and has the potential to be the first drug for acute liver disease simultaneously supporting multiple failing organs. VS-01 targets 3 rare indications and received an Orphan Drug Designation in ALF. In addition, Versantis’ pipeline promises to improve patients’ outcome in other medical fields; VS-02 and VS-03 are developed for chronic liver diseases and for the treatment of drug intoxications, both representing large market opportunities and significant upsides for Versantis.

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Investment focus

Biotechnology, Health Care, Financial Services
Seed, Funding Round, Series A
United Kingdom, United States, Switzerland

Portfolio highlights

Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.

Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies

Investment focus

Genetics, Life Science, Biotechnology
Series A
Spain

Portfolio highlights

Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.

Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic

Investment focus

Software, Health Care, Information Technology
Pre-Seed, Seed, Series A
Spain, Portugal, Poland

Portfolio highlights

Coolx — Coolx has a mission to bring technology to the service of forests. Through satellite technology and AI we help environmental consultancies, engineers and forestry managers to optimize the analysis, management and forest conservation.
Tribboo — Project management platform for construction SMEs
Nuwe — Nuwe is a startup disrupting how tech professionals get hired and improve their skills, while at the same time it changes the way companies do people management and recruitment. To achieve that,we have developed a gamified platform which allows users to take challenges, participate in projects and contribute to Nuwe’s community sharing knowledgeand helping other users out. All of this contributes to their path to getting a job and their professional self-development.Companies can ask for personalized challenges, getting access to a database of validated users. For companies, wanting to participate in Nuwe’s selection processes not only get a database of validated users, but they generate a huge impact within tech communities which helps them gain a better reputation and have access to more qualified talent in the future. Moreover, companies can also ask for internal employee analytics which will help them optimize their overall performance.

Our mission is to accelerate the transition to a new Sustainable Food System that delivers outstanding returns for investors and the planet.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Series A, Funding Round
United States, United Kingdom, France

Portfolio highlights

WOW EARN — WOW EARN connects users to the blockchain, enabling them to mine, earn, and trade via decentralised mining, earning, and trading systems.
New School Foods — Whole-muscle, plant-based seafood
Basecamp Research — Novel proteins from nature. We sample the most extreme and exciting places on the planet to build the world's largest knowledge graph of natural biodiversity.

We identify and support the most innovative European food startups and help them to thrive in the global market

Investment focus

Food and Beverage, Food Processing, Agriculture
Seed, Series A
Spain, Italy

Portfolio highlights

Cocuus — Cocuus works to create innovative and surprising culinary solutions every day. Cocuus technology introduces engineering and architecture in kitchens, giving the possibility of creating artistic culinary creations, turning dishes into a visual experience. The company was founded in 2017 and is based in Cizur Menor, Navarra, Spain.
Innomy — We developed a new generation of meat and take care of the planet.
FoodSeed — FoodSeed, the national Agrifoodtech program in Italy, along with CDP Venture Capital Sgr, Fondazione Cariverona, and UniCredit.

Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People

Investment focus

Biotechnology, Robotics, Biopharma
Pre-Seed, Funding Round
Spain

Portfolio highlights

Floatech — Floatech develops high-performance silicon anodes for advanced technology industries. Their proprietary process yields high-performance qualities in LIBs while combining manufacturing sustainability and scalability.
teknoCEA — TeknoCEA is a company expert in power electronics and R+D+i
Virmedex — Experience healthcare training with our video games, VR, and AI technology. Practice, repeat, and, most importantly... have fun!

Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.

Investment focus

Biotechnology, Wellness, Biopharma
Series A, Funding Round
Spain

Portfolio highlights

Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
ABAC Therapeutics — ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.

Union Square Ventures is a venture capital firm based in New York City.

Investment focus

Software, Financial Services, FinTech
Series A, Series B, Series C
United States, United Kingdom, Canada

Portfolio highlights

Addi — Addi is a technology company that provides credit and banking solutions. Addi is headquartered in Bogota, Colombia.
Hume AI — The AI toolkit to measure, understand, and improve how technology affects human emotion
Residua AI — A selective AI co-presence that you can summon into your digital world.

Pirate Impact is a Family office with focus on stage-agnostic direct investments in climate-tech & social impact companies in the EU & US.

Investment focus

Renewable Energy, Fuel, EdTech
Funding Round, Seed, Series C
Spain, Denmark, Germany

Portfolio highlights

XFuel — Next generation technology to produce sustainable low-carbon and powerful drop-in fuels for the Road, Marine and Aviation industries.
Labster — Labster empowers educators to reimagine their science courses with immersive online simulations. Request a demo to discover how Labster engages students, trains lab skills, and accelerates learning.
Voltfang — We integrate used electric car batteries into a battery storage system and thus build up a decentralized storage network.

International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.

Investment focus

Life Science, Biotechnology
Seed
Spain

Portfolio highlights

OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

> smart projects

Investment focus

Health Care, Cooking, Medical
Seed, Funding Round
Spain

Portfolio highlights

Qualityfry — If you are looking for an automatic commercial deep fryer for your business, check the QualityFry ones. Check out and request a demonstration
Persei vivarium (Digital Health) — Persei vivarium is a digital health business dedicated to the creation of high-quality data collections that are based on real-word data for specific diseases. The technology facilitates the capture of clinical data from the physician’s daily clinicalpractice and from the patient based on a mobile appication for remote monitoring. This provides a more holistic view and better management of the disease. The information that is captured becomes a high-value resource that also, in a simple and easy process, generates high-quality research.
Transplant Biomedicals — Diabetes can be effectively controlled by following these best tips from Diabetes Guide. You will also get to know about the tips to manage diabetes naturally

Fitalent (FIT Investment Talent SCR Simplified Regime SL) is a venture capital firm formed in early 2011 and registered in the special register of the National Securities Market Commission (CNMV), which invests in technology companies and proven successful products , whose main asset are people and talent .Their mission is to assistentrepreneurs to get consolidated, profitable and leading companies in the technology market segment. They want to be financial and strategic partners of the companies in which they participate.

Investment focus

Biotechnology, Analytics, Artificial Intelligence
Seed, Funding Round, Series A
Spain

Portfolio highlights

Citibeats — Citibeats uses AI and cutting-edge technology to transform ethically sourced public opinions into real-time, data-driven actionable insights. Monitor trends surrounding sustainability, social risk, and more.
Boxmotions — Home delivery of bulky items (furniture, home appliances, large sports equipment, etc.) is a large, growing, segregated and underserved market. Retail and e-commerce are in need of a solution that delivers quality and end customer experience standards comparable to the most innovative regular parcel delivery solutions.Boxmotions' owntechnology stack and operational processes have been meticulously curated with an end-customer-centric approach, generating capabilities unseen in the bulky items logistics industry before: scheduled time slot deliveries controlled by the end customer, delivery times x5 faster than industry average, tailored technology-guided interactions, assembly/dissassembly services, and more. We connect demand's orders with a curated pool of existing, segregated supply while guiding the whole value chain through our technology and generating incremental operational efficiency. Such model entices supply and, at the same time, provides retail and e-commerce with a capability to boost end customer experience with only competitive logistics costs.The basis of our technology stack and supply curation comes originally from an initial business line: an on-demand-storage solution for personal logistics. In our journey towards a larger market, we have always maintained our vision of making urban life easier, and more sustainable.
Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.

Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.

Investment focus

Financial Services, Software, FinTech
Debt Financing, Seed, Series A
Spain, United States, United Kingdom

Portfolio highlights

Internxt — Stand for privacy, switch to Internxt. Internxt's open-source cloud storage services protect your right to privacy. Internxt Drive, Photos, Send, and more.
Credem Banca — Scopri i servizi bancari, finanziari e assicurativi di Credem Banca per persone, famiglie e imprese. Credem, Wellbanking People.
OEG Offshore Ltd — OEG protect your offshore business through innovative, bespoke equipment and solutions designed to drive forward the offshore energy industry.

Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).

Investment focus

Medical Device, Artificial Intelligence, Medical
Seed, Funding Round, Series A
United States, United Kingdom, Spain

Portfolio highlights

LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
Rollstack — Rollstack is a tool that helps you create stunning and high-quality charts in minutes, embed data, and automate the creation of data-driven decks and docs - all within your favorite tools (Google Suite, Notion, Powerpoint)
Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit

BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.

Investment focus

Internet, Health Care, Information Technology
Seed, Angel, Funding Round
Spain, Norway, Switzerland

Portfolio highlights

Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
The Smart Lollipop — The Smart Lollipop is the non-invasive medical device in the shape of a lollipop for the diagnostic and disease monitoring through a saliva sample. The sweetest lab is The Smart Lollipop.

Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.

Investment focus

Software, FinTech, Financial Services
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

Lapse — The new social camera for friends, not followers
Inkitt — Publish stories online, join our author subscription program, and read books online for free. Join the Inkitt community for writers and readers today.
Necture — Ubiq enables mobility sharing operators to become profitable. Through demand prediction, demand fullfillment, predictive charging, dynamic pricing and policy compliance we provide tools for operational excellence.

BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.

Investment focus

Biotechnology, Health Care, Software
Seed, Pre-Seed, Series A
Canada, United States, Spain

Portfolio highlights

BioLoomics — BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
HumanFirst — The complete productivity suite to transform natural language into business insights and AI training data
Pathway Medical — Pathway is an accurate and efficient point-of-care reference tool that gives you rapid access to evidence-based guideline summaries, interactive algorithms, key findings from landmark trials, clinical calculators, and more. Available anytime, anywhere.

Amino Collective is an investment firm. They enable entrepreneurs and scientists to establish businesses that generate a better future for all species on Earth. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, life science, and synthetic biology.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Biomia — Biomia is a synthetic biology company developing plant-derived natural products for unmet medical needs in pain, addiction, and depression.
Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.

A privately held asset management company that invests in early-stage life science companies.

Investment focus

Biotechnology, Security, Health Care
Seed
Switzerland, Spain

Portfolio highlights

Bearmind — Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.
Nanoligent — Nanoligent is a biotech company, spin-off of the Universitat Autònoma de Barcelona (UAB) and Institut de Recerca de l'Hospital de la Santa Creu I Sant Pau. We are dedicated to drug design and development of targeted-therapeutic biologics .Nanoligent mision is to improve the life of patients by designing new medicines that selectively targetthe cells affected by disease. With this approach we develope treatments that are more effective and have fewer adverse effects than classical drugs.
Onena Medicines — Onena Medicines is a biotechnology company that creates innovative biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illness.

Easo Ventures es una Sociedad de Capital Riesgo Vasca y Privada, cuyo objetivo es invertir en Startups y PYMES con proyectos de crecimiento.

Investment focus

Software, Manufacturing, Health Care
Seed, Funding Round, Series A
Spain

Portfolio highlights

V2C — The smartest range of electric car chargers. Charging points compatible with all brands. [Latest technology] Discover it!
Ingelia — Ingelia is a technology-based company specializing in R & D in the renewable energy sector. Ingelia is an SME based in Valencia (Spain) owned by multinational shareholders from Spain, Austria, England, and Italy.
Begas Motor — Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate.

Clave Capital is an independent asset management company that specializes in investment strategy.

Investment focus

Biotechnology, Health Diagnostics, Health Care
Seed, Funding Round
Spain

Portfolio highlights

MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
Nanological — Nanological is a public research organization, that focuses on pathogen identification devices. Nanological is a team of biosensing experts including physicists, biologists, data scientists, finance and business development experts, and clinical validation specialists.
ADmit Therapeutics — ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.

As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.

Investment focus

Health Care, Medical Device, Health Diagnostics
Seed
Spain

Portfolio highlights

MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

We back founders who see the future differently.

Investment focus

Software, Information Technology, E-Commerce
Series A, Seed, Series B
United Kingdom, United States, Germany

Portfolio highlights

Acin — The Acin data Network and Diagnostics digitize and assure operational risk controls in a connected data Network across the industry.
Laced — Discover the latest sneaker releases with Laced. The UK and Europe's authentic sneaker marketplace, discover coveted styles from Nike, Air Jordan, Yeezy, New Balance and more. Buy and sell now with Laced.
Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.

The Green Generation Fund invests in early stage Food Tech and Green Tech companies that make our lives and diets more sustainable, healthy and ethical.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Pre-Seed, Series A
Germany, United States, Spain

Portfolio highlights

Reverion — Reverion offers electrical efficiencies for both power generation and energy storage. Reverion was foun ded in 2022 and was headquartered in Bayern, Germany.
smatch — Smatch takes care of stock management and helps retailers to better buy merchandise.
Change Foods — We (re)create real dairy foods that delight the taste buds, nourish people and sustain the planet, by using the magic of microbes instead of animals.